DOCSLIB.ORG

Thursday July 14Th

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Thursday July 14Th PRELIMINARY SCIENTIFIC PROGRAM Thursday July 14th 13:30-17:30 SPECIAL WORKSHOP WS01 WORKSHOP ON COMMUNICATION OF RESEARCH RESULTS Chaired by: Michael J. Zigmond (Pittsburgh, USA) and Beth A. Fischer (Pittsburgh, USA) 16:00-17:30 SINS SPECIAL FEATURE FOUR ITALIAN NEUROSCIENTISTS 17:30-18:30 OPENING CEREMONY EDAB PRESIDENT’S LECTURE Fifty Years of IBRO Albert J. Aguayo (Montreal, Canada) IBRO PLENARY SESSION IBRO Past Presidents & Secretary Generals awarded by Carlos Belmonte (Alicante, Spain) & Pierre Magistretti (Lausanne, Switzerland) 18:30-19:30 OPENING PLENARY LECTURE PL1 Optical technologies for probing neural signals and systems Karl Deisseroth (Stanford, USA) 19:30-20:30 WELCOME RECEPTION 1 Friday July 15th 08:30-09:30 PLENARY LECTURE PL2 Regulation and function of adult neurogenesis in the hippocampal formation Fred H. Gage (La Jolla, USA) 09:30-11:30 SYMPOSIUM S01 INTEGRATION OF NEW NEURONS IN THE ADULT BRAIN: LESSONS FOR BRAIN REPAIR Chaired by: Alejandro Fabian Schinder (Buenos Aires, Argentina) Temporal expression of neurotrophin receptors regulates newborn neuron integration into hippocampal circuits Marco Canossa (Genoa, Italy) Local network activity controls maturation and functional integration of adult-born hippocampal neurons Alejandro Fabian Schinder (Buenos Aires, Argentina) Embryonic MGE precursor cells grafted into adult rat striatum integrate and ameliorate motor symptoms in 6-OHDA-lesioned rats Veronica Martinez-Cerdeno (Sacramento, USA) Voluntary versus forced metamorphosis of astroglia into neurons Benedikt Berninger (Munich, Germany) 09:30-11:30 SYMPOSIUM S02 MOLECULAR AND CELLULAR DETERMINANTS OF NEURON/GLIA SPECIFICATION Chaired by: Flávia Carvalho Alcantara Gomes (Rio de Janeiro, Brazil) Glial cells generating neurons: molecular and cellular mechanisms Magdalena Gotz (Munich, Germany) Radial glial polarity and its contributions to neuronal migration in cerebral cortex Eva Anton (Chapel Hill, USA) Intra- and extra-cellular factors regulating neural stem cell differentiation during brain development Kinichi Nakashima (Ikoma, Japan) Cellular determinants of radial glia commitment and astrocyte differentiation: implications for synapse formation Flávia Carvalho Alcantara Gomes (Rio de Janeiro, Brazil) 09:30-11:30 SYMPOSIUM S03 ELIMINATION OF AMYLOID FROM THE AGEING AND ALZHEIMER DISEASE BRAIN: UNCLOGGING THE DAM Chaired by: Roxana Octavia Carare (Southampton, UK) 2 The prion-like aspect of cerebral amyloidosis Yvonne Eisele (Tubingen, Germany) The role of perivascular drainage in ageing Roxana Octavia Carare (Southampton, UK) Immunotherapy in Alzheimer's Disease James Nicoll (Southampton, UK) Dissolving the fibrils and targeting the phagocytes of the Alzheimer's brain JoAnne McLaurin (Toronto, Canada) 09:30-11:30 SYMPOSIUM S04 BLINDSIGHT IN ACTION: RESIDUAL VISUOMOTOR FUNCTIONS AFTER LESIONS OF PRIMARY VISUAL CORTEX Chaired by: Carlo Alberto Marzi (Verona, Italy) Goal-directed grasping and obstacle avoidance after lesions of V1 Melvyn Goodale (London, Canada) Disynaptic routes from superior colliculus to dorsal stream visual areas Ed Callaway (La Jolla, USA) Sensory-motor blindsight in the physical and social world Beatrice de Gelder (Tilburg, The Netherlands) Is blindsight mediated by the lesioned or the intact hemisphere? Carlo Alberto Marzi (Verona, Italy) 09:30-11:30 SYMPOSIUM S05 COMPUTATIONAL STUDY OF MEMORY INFORMATION PROCESSING: DATA ANALYSIS AND MODELING OF CORTICO-HIPPOCAMPAL INTERACTION Chaired by: Masami Tatsuno (Lethbridge, Canada) Cortical reactivation of recent neuronal activity patterns in the subsequent sleep is related to hippocampal activity Francesco Battaglia (Amsterdam, The Netherlands) Memory reactivation during slow-wave sleep and REM sleep Masami Tatsuno (Lethbridge, Canada) Role of the cognitive map during navigation planning: from place cells to direction cells – a computational model Colin Molter (Lausanne, Switzerland) Dynamical representation of environments in the brain Yoko Yamaguchi (Wako City, Japan) 11:30-14:30 POSTER SESSION 3 12:30-14:00 SPECIAL EVENT SE01 IPSEN FOUNDATION PRIZE AWARDS 12:30-14:00 SPECIAL EVENT SE02 MOLECULAR AND SYSTEMS NEUROBIOLOGY IN DEVELOPMENT AND DISEASE: CONTRIBUTIONS FROM IBRO ALUMNI WORLDWIDE Chaired by: Susan J. Sara (Paris, France) and Pierre Magistretti (Lausanne, Switzerland) Herbal compounds in the treatment of drug abuse: Fruit essential oil of Cuminum cyminum attenuates morphine-induced conditioned place preference Abbas Haghparast (Teheran, Iran) Herbal compounds in the treatment of psychiatric disorders:The aqueous extract of leaves of Piliostigma reticulatum possesses anxiolytic and antipyretic activity in mice Elisabeth Ngo Bum (Ngaoundere, Cameroon) In search of organizing principles during synapse elimination: Correlation between motoneuron size and position at spinal cord and motor unit innervation patterns Cristina Guatimosim (Belo Horizonte, Brazil) Molecular architecture of the hippocampal dendritic spine Bence Racz (Budapest, Hungary) 12:30-14:00 SPECIAL EVENT SE03 SINS-SDN JOINT MINISYMPOSIUM 1 14:30-16:00 WORKSHOP W01 BERGMANN GLIA CELLS IN SYNAPTIC FUNCTION Chaired by: Arturo Ortega (Mexico City, Mexico) Insights into the biological roles of Bergmann glia by transcriptional profiling Gabriel Corfas (Boston, USA) Plasticity of neuron to Bergmann glial cell transmission Tomas Bellamy (Cambridge, UK) The role of Bergmann glia for purinergic modulation of the cerebellar network Joaquim Deitmer (Kaiserslautern, Germany) Translational control of Bergmann glia/neuronal coupling Arturo Ortega (P, Mexico City, Mexico) 4 14:30-16:00 WORKSHOP W02 NEXT GENERATION SEQUENCING STRATEGIES IN NEUROGENETICS Chaired by: Guy A. Rouleau (Montreal, Canada) Personal genome analyses to elucidate the molecular pathogenesis of neurodegenerative diseases Shoji Tsuji (Tokyo, Japan) Using next generation sequencing to identify candidate genes for neurogenetic disorders Iscia Lopez-Cendes (Campinas, Brazil) Is exome sequencing the answer for definitive molecular diagnosis of the many rare hereditary neuropathies? Garth Nicholson (Sydney, Australia) Next sequencing generation in rare monogenic disorders: An experience in spinocerebellar degenerations Alexis Brice (Paris, France) 14:30-16:00 WORKSHOP W03 BASAL GANGLIA CONTROL OF SLEEP-WAKE REGULATION Chaired by: Yoshihiro Urade (Osaka, Japan) Sources and actions of adenosine in the basal ganglia Bertil Fredholm (Stockholm, Sweden) The role of adenosine A2A receptors in the nucleus accumbens for sleep-wake regulation Michael Lazarus (Osaka, Japan) Dopamine D2 receptors in the basal ganglia are essential in the maintenance of wakefulness Zhi-Li Huang (Shanghai, China) Basal ganglia control of sleep-wake behavior and cortical activation Jun Lu (Boston, USA) 14:30-16:00 WORKSHOP W04 GENETIC MOUSE MODELS TO UNDERSTAND SCHIZOPHRENIA Chaired by: Raul R. Gainetdinov (Genoa, Italy) Mouse models for genes associated with risk for psychosis: a platform for identification of novel antipsychotic targets Colm O'Tuathaigh (Dublin, Ireland) DISC1 mouse models of schizophrenia: a comparative analysis and future developments Mikhail Pletnikov (Baltimore, USA) Role of glutamatergic neurotransmission in the mechanism of action of antipsychotics Fabio Fumagalli (Milan, Italy) 5 Animal models to identify therapeutic mechanisms of antipsychotics Jean-Martin Beaulieu (Quebec, Canada) 14:30-16:00 WORKSHOP W05 ACTIVITY-DEPENDENT TRAFFICKING OF NMDA AND KAINATE RECEPTORS IN SYNAPTIC PLASTICITY Chaired by: R. Suzanne Zukin (New York, USA) Regulation of NMDA receptor trafficking by palmitoylation Richard L. Huganir (Baltimore, USA) SNAP25 is a target of PKC phosphorylation critical to NMDA receptor trafficking R. Suzanne Zukin (P, New York, USA) A role for SNAP25 in kainate receptor internalization and synaptic plasticity Juan Lerma (Alicante, Spain) Bidirectional plasticity expressed by NMDA receptors at hippocampal mossy fiber synapses Pablo E. Castillo (New York, USA) 16:00-17:30 WORKSHOP W06 REMODELLING OF NEURAL EXTRACELLULAR MATRIX IN HEALTH AND DISEASE Chaired by: Alexander Dityatev (Genoa, Italy) Extracellular matrix of perineuronal nets and neuroplasticity Alexander Dityatev (Genoa, Italy) Matrix metalloproteinase MMP-9 in synaptic plasticity, elipeptogenesis and drug addiction Leszek Kaczmarek (Warsaw, Poland) The neurotrypsin/agrin system – its roles in mental retardation and activity-dependent structural plasticity in the CNS Peter Sonderegger (Zurich, Switzerland) Plasminogen activating system in post-injury recovery and epileptogenesis Asla Pitkanen (Kuopio, Finland) 16:00-17:30 WORKSHOP W07 NEUROBIOLOGICAL BASIS OF EMERGING THERAPIES IN DRUG ADDICTION Chaired by: Gaetano Di Chiara (Cagliari, Italy) The dopamine hypothesis of drug addiction Marco Diana (Sassari, Italy) The human dopamine system in addiction Diana Martinez (New York, USA) Interaction between 5-HT and DA in relation to the treatment of psychostimulant dependence Valentina Valentini (Cagliari, Italy) 6 Forgetting to be addicted by brain stimulation: from animal models to human application Abraham Zangen (Rehovot, Israel) 16:00-17:30 WORKSHOP W08 HABILITATION OF HEARING IN THE 21ST CENTURY Chaired by: Edwin W. Rubel (Seattle, USA) Challenges for hair cell regeneration as a therapy for deafness Andrew Forge (London, UK) Novel therapies for noise-induced hearing loss based on the actions of insulin-like growth factor 1 and transforming growth factor β2 Isabel Varela (Madrid, Spain) Targeting cell cycle molecules and tumor suppressors for therapeutic
Load more

Recommended publications
  • Curriculum Vitae
    CURRICULUM VITAE Name Pierre J. MAGISTRETTI Date of birth September 30, 1952 Citizenship Swiss Marital status Married to Christine E. Naville Three children: Ambroise (1984), Bérénice (1987) and Henri (1990) Professional address Brain Mind Institute, EPFL CH-1015 Lausanne (Switzerland) Division of Biological and Environmental Sciences and Engineering KAUST, Thuwal, 23955-6900 (Kingdom of Saudi Arabia) E-mail: [email protected] EDUCATION 1982 Doctor of Philosophy Degree in Biology (Ph.D.), University of California at San Diego, (Advisors: Drs Floyd E. Bloom and Silvio Varon) 1979 Doctorat en Médecine (M.D.), University of Geneva 1977 Diplôme Fédéral de Médecin, University of Geneva Educational Commission for Foreign Medical Graduates Examination 1970 Maturité Fédérale Type A (Classical studies). MAIN POSITIONS HELD 2012 - Distinguished Professor, Division of Biological and Environmental Sciences and Engineering, KAUST, Thuwal 2005 - Professor, Brain Mind Institute, Swiss Federal Institute of Technology (EPFL) 2004 – 2012 Professor, Center for Psychiatric Neuroscience, Department of Psychiatry University of Lausanne Medical School and Hospitals (UNIL-CHUV) 2008 - 2012 Director, Brain Mind Institute, Federal Institute of Technology (EPFL), Lausanne (Joint appointment with UNIL-CHUV) 2005 - 2008 Co-Director, Brain Mind Institute, Federal Institute of Technology (EPFL), Lausanne (Joint appointment with UNIL-CHUV) 2001 - 2003 Chairman, Department of Physiology, University of Lausanne Medical School (Co-Chairman in 2004) 1996 - 2000
    [Show full text]
  • Cell Type-Specific Long-Term Plasticity at Glutamatergic Synapses Onto Hippocampal Interneurons Expressing Either
    The Journal of Neuroscience, January 27, 2010 • 30(4):1337–1347 • 1337 Behavioral/Systems/Cognitive Cell Type-Specific Long-Term Plasticity at Glutamatergic Synapses onto Hippocampal Interneurons Expressing either Parvalbumin or CB1 Cannabinoid Receptor Wiebke Nissen,1 Andras Szabo,1 Jozsef Somogyi,2 Peter Somogyi,2 and Karri P. Lamsa1 1Department of Pharmacology, Oxford University, Oxford OX1 3QT, United Kingdom, and 2Medical Research Council Anatomical Neuropharmacology Unit, Oxford University, Oxford OX1 3TH, United Kingdom Different GABAergic interneuron types have specific roles in hippocampal function, and anatomical as well as physiological features vary greatly between interneuron classes. Long-term plasticity of interneurons has mostly been studied in unidentified GABAergic cells and is known to be very heterogeneous. Here we tested whether cell type-specific plasticity properties in distinct GABAergic interneuron types might underlie this heterogeneity. We show that long-term potentiation (LTP) and depression (LTD), two common forms of synaptic plasticity, are expressed in a highly cell type-specific manner at glutamatergic synapses onto hippocampal GABAergic neurons. Both LTP and LTD are generated in interneurons expressing parvalbumin (PVϩ), whereas interneurons with similar axon distributions but expressing cannabinoid receptor-1 show no lasting plasticity in response to the same protocol. In addition, LTP or LTD occurs in PVϩ interneurons with different efferent target domains. Perisomatic-targeting PVϩ basket and axo-axonic interneurons express LTP, whereas glutamatergic synapses onto PVϩ bistratified cells display LTD. Both LTP and LTD are pathway specific, independent of NMDA receptors, and occur at synapses with calcium-permeable (CP) AMPA receptors. Plasticity in interneurons with CP-AMPA receptors strongly modulates disynaptic GABAergic transmission onto CA1 pyramidal cells.
    [Show full text]
  • Floreat Domus 2011
    ISSUE NO.17 april 2011 Floreat Domus BALLIOL COLLEGE NEWS Special Feature: More than money Three Balliol Old Members talk about aid work People-powered politics Master on the move Stop Press: Election of New Master Balliol College is very pleased to announce that it has offered Contents the Mastership of the College Welcome to the 2011 to Professor Sir Drummond Bone (1968), MA DLitt DUniv edition of Floreat Domus. (Glas) FRSE FRSA, and he has accepted. The formal election will be in Trinity Term. contents page 28 Putting Margate Professor Bone will take up the back on the map post this October. For more page 1 College news The new Turner Contemporary information, go to www.balliol. page 6 Women at Balliol gallery, involving three Old Members ox.ac.uk/news/2011/march/ election-of-new-master page 8 College success page 30 In the dark without page 9 Student news nuclear power? Roger Cashmore and David Lucas page 10 Student success discuss the future of nuclear power Special feature Page 20–23 Page 39 A map of the heart page 12 page 32 Great adventurers 50th anniversary of Denis Noble’s The amazing trips made by Sir ground-breaking paper Adam Roberts and Anthony Smith Talking science page 13 page 33 Bookshelf in the centre of Oxford A selection of books published page 14 The Oxford by Balliol Old Members Student Consultancy page 34 Master on the move: page 15 The Oxford conversations around the world Microfinance Initiative Andrew and Peggotty Graham talk about their round-the-world trip Features Development news page 16 People-powered politics
    [Show full text]
  • La Passion Pour La Recherche
    DES GENS DES PASSIONS Le professeur Pierre Magistretti La passion pour la recherche CATHY PREMER Pierre Magistretti est un passionné de recherche. INTÉRÊT POUR LE FONCTIONNEMENT DU Les résultats de ses travaux ont permis des CERVEAU avancées conséquentes notamment dans le Très vite il montre un vif intérêt pour le domaine de la protection des neurones. Ce médecin fonctionnement du cerveau. Sa passion et neurobiologiste, né de parents médecins milanais, pour la recherche l’amène à explorer de étudie à Milan jusqu’à ses 10 ans. Il poursuit ensuite nouveaux champs. Il entame un doctorat en sa scolarité à Crans-Montana et retourne en Italie, neurosciences à l’Université de Californie cette fois à Rome où il finit ses études secondaires. à San Diego. Lors de sa thèse il découvre Grandissant dans un terreau scientifique, sa mère les fonctions des cellules non neuronales ayant beaucoup de contacts internationaux, cette (cellules gliales), qui détectent quand les dernière lui fait rencontrer des personnes de référence, neurones sont actifs et leur fournissent quelques prix Nobel de médecine. Pierre Magistretti de l’énergie à la demande. Ses travaux retournera en Suisse pour étudier la médecine à ont permis entre autres de comprendre l’Université de Genève. l’origine des signaux qui sont détectés par | 12 | DES GENS DES PASSIONS les techniques d’imagerie cérébrale fonctionnelle et certains mécanismes de la plasticité neuronale liée au processus de mémoire ; de développer des molécules qui puissent agir pour protéger les neurones, activité qui fait l’objet d’une start-up, GliaPharm, qu’il a démarré avec des collègues de l’Ecole polytechnique fédérale de Lausanne.
    [Show full text]
  • The Clinical and Genetic Heterogeneity of Paroxysmal Dyskinesias
    doi:10.1093/brain/awv310 BRAIN 2015: 138; 3567–3580 | 3567 The clinical and genetic heterogeneity of paroxysmal dyskinesias Alice R. Gardiner,1,2 Fatima Jaffer,1,2 Russell C. Dale,3 Robyn Labrum,4 Roberto Erro,5 Esther Meyer,6 Georgia Xiromerisiou,2,7 Maria Stamelou,5,8,9 Matthew Walker,10 Dimitri Kullmann,10 Tom Warner,2 Paul Jarman,5 Mike Hanna,1 Manju A. Kurian,6,11 Kailash P. Bhatia5,* and Henry Houlden1,2,4,* Downloaded from ÃThese authors contributed equally to this work. Paroxysmal dyskinesia can be subdivided into three clinical syndromes: paroxysmal kinesigenic dyskinesia or choreoathetosis, paroxysmal exercise-induced dyskinesia, and paroxysmal non-kinesigenic dyskinesia. Each subtype is associated with the known http://brain.oxfordjournals.org/ causative genes PRRT2, SLC2A1 and PNKD, respectively. Although separate screening studies have been carried out on each of the paroxysmal dyskinesia genes, to date there has been no large study across all genes in these disorders and little is known about the pathogenic mechanisms. We analysed all three genes (the whole coding regions of SLC2A1 and PRRT2 and exons one and two of PNKD) in a series of 145 families with paroxysmal dyskinesias as well as in a series of 53 patients with familial episodic ataxia and hemiplegic migraine to investigate the mutation frequency and type and the genetic and phenotypic spectrum. We examined the mRNA expression in brain regions to investigate how selective vulnerability could help explain the phenotypes and analysed the effect of mutations on patient-derived mRNA. Mutations in the PRRT2, SLC2A1 and PNKD genes were identified in 72 families in the entire study.
    [Show full text]
  • Curriculum Vitae Vwy 2018
    Yong 1 CURRICULUM VITAE, V. WEE YONG October 2018 Synopsis: Research interests lie in the area of neuroimmunology, neuroprotection and CNS regeneration, and projects are guided by multiple sclerosis (MS) and glioblastomas Published 290 peer-reviewed manuscripts that have been cited over 19,000 times with a h- index of 78 (Web of Science) A leader in translating laboratory findings into clinical trials, including Phase III trials in MS and traumatic spinal cord injury; recently received funding for a Phase I/IIa trial in glioblastoma President of the International Society of Neuroimmunology (ISNI) (2014-2016) Past trainees have excelled, including 25 in professorial positions worldwide and 17 medical specialists. I currently mentor 6 fellows, 3 PhD and 3 MSc students Directs the Alberta MS Network that facilitates training and multi-disciplinary collaboration on MS across Alberta Leads the Americas and Global Schools of Neuroimmunology for ISNI Elected fellow of both the Canadian Academy of Health Sciences (2010) and the Royal Society of Canada (2014) Recipient of the 2017 Allyn Taylor International Prize in Medicine for “transformational discoveries in MS” A. IDENTIFICATION Name: V. Wee Yong Current Position: Professor, University of Calgary Canada Research Chair in Neuroimmunology (Tier 1) Office Address: Hotchkiss Brain Institute and Departments of Clinical Neurosciences and Oncology University of Calgary 3330 Hospital Drive NW Calgary, Alberta T2N 4N1 Telephone: 403-220-3544 Fax: 403-210-8840 E-mail: [email protected] Spouse: Fiona P. Yong Children: Sasha, Emma and Heather B. EDUCATION Undergraduate: University of Manchester, Manchester, England Pharmacology, B.Sc. (Hons), 1978 - 1981 Graduate: University of British Columbia, Vancouver, Canada Yong 2 Pharmacology and Neurochemistry, Ph.D., 1981 - 1986 Supervisor: Dr.
    [Show full text]
  • MRC Centre Phd Students, Research Fellows and Projects Since Centre Inception (2008)
    MRC Centre PhD Students, Research Fellows and Projects Since Centre Inception (2008) Current students – clinical (by start date) Clinical current students (by start date) Menelaos Pipis Start date: August 2017 PhD Project Title: The causes and pathogenesis of inherited peripheral neuropathies Supervisors: Professor Mary M Reilly, Dr Alexander M Rossor Funding Source: National Institute of Health Fellowship (Inherited Neuropathy Consortium) Length of studentship: 3 years Project Description: Charcot-Marie-Tooth (CMT) and related conditions are the commonest inherited neuromuscular diseases with a population prevalence of 1 in 2500. As a scientific community we have entered an exciting therapeutic era, where advances in cell biology and animal models of CMT are paving the way for rational treatments and this has accelerated the need to improve our diagnostic rate and accuracy. Despite the discovery of more than 90 causative CMT genes through the advent and use of next-generation sequencing (NGS) technologies, there are still patients with specific subtypes of CMT, such as CMT2 and distal Hereditary Neuropathy (dHMN) that remain without a genetic diagnosis. Through the use of whole exome and whole genome sequencing, I endeavour to identify new pathogenic genetic variants of CMT and through functional assays and where possible transcriptomic analysis, study the effect of non-coding variants in the pathogenesis of CMT. Laura Nastasi Photo not supplied Start date: March 2017 PhD Project Title: A natural history study of adults with Duchenne Muscular Dystrophy living in the UK Supervisors: Dr Ros Quinlivan, Professor Michael Hanna Funding Source: Muscular Dystrophy UK Clinical Training Length of studentship: 4 years (plus 6-month extension for maternity leave) Project Description: Duchenne muscular dystrophy (DMD) is an inherited progressive disorder affecting about 2,500 boys living in the UK.
    [Show full text]
  • Preliminary Program
    Preliminary Program Wednesday, 22 September, 2021 7:00 pm Get-Together Thursday, 23 September, 2021 8:30-8:40 am Introduction: Holger Lerche (Tübingen) 8:40-9:40 am Session 1: Neurodevelopmental changes of excitability (15 + 5 min each) Chair: Massimo Mantegazza (Nice) & Camila Esguerra (Oslo) 8:40 Olga Garaschuk (Tübingen): Developmental changes in neocortical network activity 9:00 Knut Kirmse (Jena): Multiple functions of GABA during brain development 9:20 Dirk Isbrandt (Cologne/Bonn): Developmental windows of opportunity 09:40-11:05 am Session 2: From Genotype to Phenotype (15 + 5; 20 + 5 for 2 speakers) Chair: Rikke Møller (Dianalund) & Ulrike Hedrich (Tübingen) 9:40 Rima Nabbout (Paris): Overview of developmental and epileptic encephalopathies 10:00 Rikke Møller (Dianalund) & Yuanyuan Liu (Tübingen): SCN8A variants causing epilepsy or intellectual disability 10:25 Camila Esguerra (Oslo): Zebrafish models: Scn1a and beyond 10:45 Ethan Goldberg (Philadelphia): Mechanisms of SCN3A-related neurodevelopmental disorders 11:05-11:30 am Coffee Break 11:30 am-12:30 pm Session 3: Perspectives of gene therapy (15 + 5 min each) Chair: Dirk Isbrandt (Cologne/Bonn) & Niklas Schwarz (Tübingen) 11:30 Snezana Maljevic (Melbourne): Antisense oligonucleotide therapies for neurogenetic disorders 11:50 Dimitri Kullmann (London): Gene therapy in epilepsy 12:10 Federico Zara (Genoa): Promoter-enhancing gene therapies 12.30-1:30 pm Lunch Break 1:30–3:40 pm Session 4: From molecules to networks (15 + 5 min each) Chair: Dimitri Kullmann (London) & Heinz Beck
    [Show full text]
  • Due to the Corona Pandemic, the Conference Will Take Place Virtually
    Fall meeting of the Belgian Society of Pediatric Neurology Friday 20 November 2020 Channels in paediatric neurology From physiopathology to therapeutic opportunities Dear Colleagues It is our great pleasure to invite you to the fall meeting of the Belgian Society of Pediatric Neurology which will take place in the center of Ghent, 20 November 2020. The theme of the scientific program is “Channels in paediatric neurology, from physiopathology to therapeutic opportunities” with the participation of experts in the field. With kind regards The team of Pediatric Neurology, University Hospital Ghent Coronavirus measures Due to the corona pandemic, the conference will take place virtually Participation fee BSPN member free of charge Non-BSPN member 50 € Students and residents 25 € Registration Online registration on the website of the Belgian Society of Pediatric Neurology is required. The link for participation will be sent later by email. Payment Bank transfer: IBAN BE38 2100 0475 5072 (BSPN); BIC GEBABEBB mention 'name + registration BSPN fall meeting 2020'. Free communications Colleagues are encouraged to submit a scientific abstract. Free communications related to the main topic are most appreciated. Abstracts should be sent only by email to [email protected] BEFORE 28 October 2020. Clearly indicate title, authors, address, and e-mail address. The abstract should be typed in Word and not exceed 2000 characters. Meeting language will be English Accreditation requested With the support of Channels in paediatric neurology From physiopathology
    [Show full text]
  • Lactate in the Brain: from Metabolic End-Product to Signalling Molecule
    REVIEWS Lactate in the brain: from metabolic end-product to signalling molecule Pierre J. Magistretti1,2,3* and Igor Allaman2 Abstract | Lactate in the brain has long been associated with ischaemia; however, more recent evidence shows that it can be found there under physiological conditions. In the brain, lactate is formed predominantly in astrocytes from glucose or glycogen in response to neuronal activity signals. Thus, neurons and astrocytes show tight metabolic coupling. Lactate is transferred from astrocytes to neurons to match the neuronal energetic needs, and to provide signals that modulate neuronal functions, including excitability, plasticity and memory consolidation. In addition, lactate affects several homeostatic functions. Overall, lactate ensures adequate energy supply, modulates neuronal excitability levels and regulates adaptive functions in order to set the ‘homeostatic tone’ of the nervous system. Pyruvate dehydrogenase When studied at the organ level, brain energy meta­ Notably, under physiological conditions, the (PDH). The first component bolism can be considered as being almost fully oxida­ lactate:pyruvate concentration ratio is at least 10:1 enzyme of the pyruvate tive: elegant studies pioneered in the 1940s and 1950s (REF. 11). Thus, when considering the intercellular trans­ dehydrogenase complex; by Schmitt and Kety1 and later by Sokoloff 2 showed fer of a glycolytic substrate, lactate is the predominant it converts pyruvate into acetyl-CoA, which enters the that glucose is the obligatory physiological energy substrate in the brain. This ratio can also massively tricarboxylic acid (TCA) cycle substrate of the brain and is metabolized to CO2 and increase under hypoxia, as decreases in the partial for cellular respiration.
    [Show full text]
  • Presynaptic Action Potential Modulation in a Neurological Channelopathy
    Presynaptic action potential modulation in a neurological channelopathy Umesh Saravanan Vivekananda No: 110091548 A thesis submitted to University College London for the degree of Doctor of Philosophy Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology April 2017 1 Declaration I, Umesh Vivekananda, confirm that the work presented in this thesis is my original research work. Where contributions of others are involved, this has been clearly indicated in the text. 2 Abstract Channelopathies are disorders caused by inherited mutations of specific ion channels. Neurological channelopathies in particular offer a window into fundamental physiological functions such as action potential modulation, synaptic function and neurotransmitter release. One such channelopathy Episodic Ataxia type 1 (EA1), is caused by a mutation to the gene that encodes for the potassium channel subunit Kv1.1. This channel is predominantly found in presynaptic terminals and EA1 mutations have previously been shown to result in increased neuronal excitability and neurotransmitter release. A possible reason is that presynaptic action potential waveforms are affected in EA1. Thus far, direct electrophysiological recording of presynaptic terminals has been limited to large specialised synapses e.g. mossy fibre boutons, or axonal blebs, unnatural endings of transected axons. This is not representative of the vast majority of small synapses found in the forebrain. Using a novel technique termed Hopping Probe Ion Conductance Microscopy (HPICM) I have been able to directly record action potentials from micrometer sized boutons in hippocampal neuronal culture. I have shown that in a knockout model of Kv1.1 and in a knockin model of the V408A EA1 mutation, presynaptic action potentials are broader than in wild type; however action potentials are unaffected in the cell body.
    [Show full text]
  • Glycogen: a Trojan Horse for Neurons
    NEWS AND VIEWS Glycogen: a Trojan horse for neurons Pierre J Magistretti & Igor Allaman Neural activity leads to the mobilization of energy from glycogen in astrocytes. A new paper reports that neurons have an ambivalent relationship with glycogen: they can synthesize it themselves, but that synthesis induces apoptosis. Presumably for this reason, neurons normally inhibit glycogen synthesis through two redundant pathways. Glycogen, the single largest energy reserve of the brain1, is mobilized by neuronal activity2, probably to match the increased a b energy requirements associated with it. NA,VIP, ADE, ATP Glycogen metabolism provides a clear Astrocyte http://www.nature.com/natureneuroscience example of neuron-glia metabolic coupling. Glycogen GS P ‘Glycogen’ P P Malin Glycogen is almost exclusively localized in P GS P PTG LiCl PP Laforin astrocytes, whereas the neurotransmitters P Lactate P P P Malin P GS P Laforin and neuromodulators that mobilize glycogen PPP are released by active neurons3. Neuron Glycogen is regulated by two key enzymes, glycogen synthase and glycogen phosphorylase. Phosphorylation inhibits glycogen synthase and Ris-Vicari Katie increases the activity of glycogen phosphorylase, resulting in glycogenolysis. In cortical slices, Figure 1 Glycogen metabolism in the brain and its dysregulation in Lafora disease. (a) Under normal glycogenolysis is triggered by noradrenaline, circumstances, astrocytes synthesize and store glycogen. Neurotransmitters such as noradrenaline Nature Publishing Group Group Nature Publishing (NA), vasoactive intestinal peptide (VIP), adenosine (ADE) or ATP trigger the breakdown of glycogen 7 vasoactive intestinal peptide, adenosine to enable the release of lactate, which is taken up as fuel by neurons. In neurons, glycogen 1 200 and ATP through cyclic AMP– or calcium- synthase (GS) is hyperphosphorylated and thereby inactivated.
    [Show full text]